sorafenib has been researched along with fosbretabulin in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (fosbretabulin) | Trials (fosbretabulin) | Recent Studies (post-2010) (fosbretabulin) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 497 | 0 | 320 |
| 6,520 | 730 | 5,251 | 588 | 21 | 310 |
| Protein | Taxonomy | sorafenib (IC50) | fosbretabulin (IC50) |
|---|---|---|---|
| Tubulin polymerization-promoting protein | Homo sapiens (human) | 1.016 | |
| Tubulin alpha-1A chain | Sus scrofa (pig) | 1.82 | |
| Tubulin beta chain | Sus scrofa (pig) | 1.9428 | |
| Tubulin beta-4A chain | Homo sapiens (human) | 1.663 | |
| Tubulin beta chain | Homo sapiens (human) | 1.663 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 0.009 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 1.663 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 1.08 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 1.005 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.81 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 1.2 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 1.663 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 1.663 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 1.663 | |
| Vesicular acetylcholine transporter | Tetronarce californica (Pacific electric ray) | 1.8 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 1.5801 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 1.663 | |
| Beta-tubulin | Leishmania donovani | 1.95 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 1.663 | |
| Tubulin beta-2B chain | Bos taurus (cattle) | 1.4484 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 1.663 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 1.663 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 1.4928 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 1.4037 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 1.663 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 1.663 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 1.663 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 1.6366 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carda, M; Conesa-Milián, L; Falomir, E; Marco, JA; Murga, J | 1 |
| Chen, X; Liu, Y; Liu, Z; Ma, S; Sakurai, K; Song, W; Tang, Z; Wang, G; Wang, Y; Yu, H; Zhang, D | 1 |
2 other study(ies) available for sorafenib and fosbretabulin
| Article | Year |
|---|---|
Synthesis and biological evaluation as antiangiogenic agents of ureas derived from 3'-aminocombretastatin A-4.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Stilbenes; Urea; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
Co-administration of combretastatin A4 nanoparticles and sorafenib for systemic therapy of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Death; Cell Survival; Human Umbilical Vein Endothelial Cells; Humans; Ki-67 Antigen; Liver Neoplasms; Male; Mice, Inbred BALB C; Nanoparticles; Platelet Endothelial Cell Adhesion Molecule-1; Sorafenib; Stilbenes; Treatment Outcome; Vascular Endothelial Growth Factor A | 2019 |